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Abstract
Objective: Since the introduction of the liquid-based ThinPrep testing in 1996, most cytology laboratories
across the country have adopted the liquid-based cytology (LBC) for Pap test screening. Subsequent to
wide-spread adoption of the ThinPrep Pap test, the ThinPrep Imaging System (TIS) Cytyc Corp,
Marlborough, MA was introduced to improve the accuracy and efficiency of screening interpretation. We
report our initial experience with the TIS at Magee Women's Hospital. We introduced the TIS in December
2004.
Methods: The imager assisted Pap test results over the first 12 months (December 2004 to December
2005) of implementation were reviewed and analyzed. Our implementation protocol included each
cytotechnologist manually prescreening 200 negative slides to gain experience with the imager slides and
serve as a quality check for the TIS. We re-screened 3400 slides (200 slides each for 17 cytotechnologists)
manually which were initially determined to be negative using the TIS. 104,457 Pap tests were imaged on
the TIS. 95,899 manually screened Pap tests, 12 months prior to the introduction of the TIS (December
2003–November 2004) are taken as the historic control group for our study.
Results: The mean ASC-US rate employing the automated imager was 8.70% [9088/104,457]. The mean
LSIL detection rate was 4.22% [4409/104,457]. The imager did not miss any detectible high-grade lesions
during these months, with a HSIL (+) detection rate of 0.68% in comparison to 0.60% by manual screening
confirmed by follow-up biopsies. The difference is statistically significant with a p value of 0.022. The
definition of false negative rate for purposes of this study is calculated as the number of false negative cases
identified out of number of negatives re-screened. The TIS false negative rate was estimated at 0.012% [4/
3400].
Conclusion: The overall performance of the TIS in our lab appears to be highly satisfactory in terms of
improving sensitivity in screening cervical precursor lesions. The increased accuracy of detection of HSIL
indicates a positive impact of the TIS in our laboratory.
Background
Primary cervical cancer screening techniques have under-
gone revolutionary changes since the introduction of con-
ventional Pap smears in 1946. Liquid based Pap tests
intended as a replacement for the conventional smears
received FDA approval in 1996 for cervical cancer screen-
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ing. In countries where cervical cancer screening is a rou-
tine procedure, manual screening of slides has always
been a laborious task. There have been methods put for-
ward to improve the assisted screening techniques. The
Cytyc Corporation ThinPrep®  Imaging system (TIS), a
computer imaging based technology, is one of the recent
devices introduced to assist in primary cervical screening
of ThinPrep Test slides for the presence of epithelial cell
abnormalities as defined by the 2001 Bethesda System for
Reporting Cervical Cytology (TBS)[1,2].
The TIS consists of an image processor connected to one
or more review scopes. The review scope is a microscope
connected to the imager with an automated stage and a
control pad connected via Ethernet cables to enable locat-
ing 22 fields of interest. These fields are screened by the
cytotechnologist for the presence of abnormal cells. The
cytotechnologist can verify negative reports in the absence
of abnormal cells, or rescreen the entire slide if there are
any abnormal questionable cells detected by the TIS [2].
Of the centers which have validated and reported their
experiences with the TIS imager, most are still in the form
of abstracts [8-19], with available peer-reviewed papers
reflecting data from the clinical trial studies [3,4]. A multi-
center clinical trial has shown that the TIS is more sensi-
tive than manual screening for Atypical Squamous Cells
of Undetermined Significance or Higher [ASC-US (+)],
while its sensitivity in the clinical trials was equivalent for
Low grade squamous intraepithelial lesion (LSIL (+)) and
High-grade squamous intraepithelial lesion (HSIL (+))
results. On the other hand, the specificity at the level of
HSIL (+) exceeded that for ASC-US (+) and LSIL (+) [3].
The TIS was introduced in our lab recently in December
2004. Our study is one of the first to evaluate the initial
performance of the TIS imager in a high volume academic
hospital laboratory. Pap Tests that were manually
screened during the 12-month period prior to the intro-
duction of the TIS in our laboratory were used as the his-
torical control group for our study.
Materials and methods
The TIS was introduced in our hospital pathology labora-
tory in 2004. 104,457 Pap tests were imaged by the TIS in
the 12-month period, December 2004–December 2005.
95,899 manually screened Pap tests, 12 months prior to
the introduction of the TIS (December 2003–November
2004) are taken as the historic control group for our study.
The salient features of both the comparison and the con-
trol groups include: 1) The TIS cohort and the control
cohort are derived from the same practice and belong to
the same demographic population. 2) The same cytotech-
nologists screened the Pap tests of both groups.
The cytological specimens collected routinely from the
clinics were prepared using the ThinPrep 3000 Processor
(Cytyc Corp) according to the manufacturer's instruc-
tions. Essentially, the vials containing the cells are placed
in the processor and a dispersion cycle homogenizes the
cell suspension. The cells are automatically collected on a
polycarbonate filter membrane. A thin, evenly dispersed
monolayer of cells is deposited from the filter onto the
slide in a 20 mm circle. Extraneous mucus and blood are
removed in the process. The slides are manually removed
from the processor and stained by the Pap method. The
specimen adequacy was recorded according to 2001 TBS
guidelines [1]. When the TIS was introduced, our protocol
initially included each cytotechnologist manually screen-
ing 200 slides to get acquainted with the imager slides.
This also served as a quality check for the TIS imager. The
definition of false negative rate for purposes of this study
is calculated as the number of false negative cases identi-
fied out of number of negatives re-screened.
Results
Among the 104,457 Pap tests imaged, 1176 were reported
as unsatisfactory following the TBS criteria [1]. The mean
rate of detection of ASC-US by the TIS was 8.70%. The
mean detection rate of LSIL by the TIS was 4.22% and the
ASCUS/LSIL ratio was 2.06%. In the comparative group of
the manual screening (MS) from the prior 12 months
(January 04–December 04), 95,899 Pap tests were manu-
ally screened of which 1725 were interpreted as unsatis-
factory. The mean rate of detection of ASC-US by manual
screening was 8.79%. The detection rate of LSIL by man-
ual screening was 3.90% and the ASCUS/LSIL ratio was
2.25%. There is an difference in the detection rates of LSIL
by TIS. On the other hand there is a slight decrease in the
detection rates of ASC-US and AGC categories There is an
increase in the detection rates of ASC-H by the TIS as com-
pared to MS.(0.6% vs 0.5%). The imager did not miss any
detectible high-grade lesions, with detection rate of HSIL
(+) of 0.68% in comparison to 0.60 % by manual screen-
ing. The difference is statistically significant with a p value
of 0.022. A comparison of the various abnormal interpre-
tations by the TIS versus manual screening is shown in
[Table 1, Fig 1]. The HSIL(+) Pap tests are confirmed by
follow-up colposcopic biopsies. There is an overall
increased rate of detection of cervical intraepithelial neo-
plasia (CIN) observed in the follow-up biopsies by 2%.
The increase is seen more so in the CIN 1 category [Table
3]. Follow-up biopsies results of ASC-H and HSIL (+) are
shown in Tables 3, 4. A comparison of these tables show
that there is certainly improved detection of CIN 1 w/HSIL
+ and ASC-H interpretation (195 vs. 134 & 232 vs. 161).
There is also improved detection of CIN 2(+) by TIS (281
vs 232). In the follow-up biopsies of ASC-H cases, there is
slightly decreased number of CIN 2(+) (39 vs 45). The
two possible explanations for this might be a shift in the
clinicians ordering HPV testing for ASC-H interpretation,
that we are noticing now or these are more specifically
interpreted as HSIL(+) (that can explain the increase in
HSIL(+)rates). Overall there is an increase in ASC-H inter-
pretation but at the expense of PPV for CIN 2(+) [Table 3].
Four cases were missed by the TIS with a false negative rate
of 0.012 % (4/3400). Of the four cases missed, two casesCytoJournal 2007, 4:6 http://www.cytojournal.com/content/4/1/6
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Table 2: Follow-up biopsy results of the missed cases by TIS
Case # Pap Test interpretation F/u biopsy result
1 Low-grade squamous intraepithelial lesion (LSIL) Cervical intraepithelial neoplasia 1(CIN 1)
2 Low-grade squamous intraepithelial lesion (LSIL) No follow-up biopsy
3 Low-grade squamous intraepithelial lesion (LSIL) *No follow-up biopsy
4 Low-grade squamous intraepithelial lesion (LSIL) ECC – Negative
*: Follow-up pap tests were ASCUS/HPV+ & LSIL (CIN 1)
Table 1: A comparison of various cytological diagnoses by Manual screening vs. TIS
Manual Screening [%] TIS Screening [%]
ASC-US 8.79 [8425/95,899] 8.70 [9088/104,457]
LSIL 3.90 [3744/95,899] 4.22 [4409/104,457]
HSIL (+)* 0.60 [577/95,899] 0.68 [714/104,457]
ASC-H 0.50 [475/95,899] 0.60 [634/104457]
AGC 0.30 [284/95,899] 0.28 [292/104,457]
* -HSIL (+) encompasses HSIL (CIN2.3), Carcinoma-in-situ (CIS) and invasive carcinoma (squamous & adenocarcinoma)
Table 3: Biopsy follow-up of ASC-H category
Year Total# Bxs done NEG CIN 1 CIN 2+ No f/u
2005 (N = 634) 414 143 [34.5%] 232 [56%] 39 [9.4%] 220 [35%]
2004 (N = 475) 232 133 [57.3%] 161 [69.3%] 45 [19.4%] 136 [28.6%]
Table 4: Biopsy follow-up of HSIL (+) category
Year Total# Bxs done NEG CIN 1 CIN 2+ No f/u
2005 (N-714) 520 44 [8.5%] 195 [38%] 281 [54%] 194 [27%]
2004 (N-577) 408 42 [10.3%] 134 [33%] 232 [57%] 169 [29%]CytoJournal 2007, 4:6 http://www.cytojournal.com/content/4/1/6
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were rescreened by the cytotechnologist due to the previ-
ous history of abnormal pap. Two cases were detected by
random screening by the cytotechnologist. The follow-up
cervical biopsy in one case showed CIN1. Two cases did
not have follow-up biopsies. In one case, an endocervical
curettage (ECC) was performed and is negative [Table 2].
Discussion
The methods of cervical cancer screening in the past 50
years have undergone major changes. The introduction of
liquid based cytology screening and FDA approval of the
HPV-DNA testing with the Pap test have added new
dimension to the Pap test screening. The introduction of
the ThinPrep method for LBC has shown superiority over
conventional screening methods in several meta-analyses
[5,7]. Reference studies have shown that there is more
uniform cellular distribution, better morphological pres-
ervation and a cleaner background observed in the Thin-
Prep slides during the screening process [5].
The concept of computer assisted primary screening was
to assist both screening accuracy and productivity [3]. The
intent of the TIS was to assist the cytotechnologists in the
difficult and tedious primary screening process [3]. Stud-
ies have been conducted to compare the image-assisted
primary screening versus manual ThinPrep screening
[8,9,13,14]. A multi-center two-armed clinical trial to
evaluate the performance of the TIS revealed some prom-
ising results. The imager was found to have a significantly
higher sensitivity in detection of ASC-US (+) with an
increase of 6.4% as compared to the manual review
method [3]. In our lab, the mean ASC-US rate and the
ASCUS/LSIL rate showed a slight increase in comparison
to the manual screening.
The detection rates of LSIL (+) in some studies on the TIS,
showed a statistically significant increase in comparison
to manual screening [14]. In our lab the mean LSIL rate
(4.08%) by the TIS showed an increase by 8.2% as com-
pared to the control MS group (4.03%). Our results are
comparable with the other studies [3,8,12-14,18]. The
most important clinical aspect of cervical cancer screening
is detection of HSIL (+). In all the studies done so far on
the TIS, there has been a noticeable increase in detection
of HSIL (+) [3,9,13-15]. We now present a similar experi-
ence with the TIS in our lab. The detection rate of HSIL (+)
by the TIS was 0.68%  which is more than by the MS
0.60%. There is a significant increase in the detection rate
noted by 13.3%. The combined detection rates of Atypical
squamous cells, cannot exclude HSIL (ASC-H) and HSIL
(+) have also shown a significant increase by 16% as com-
pared to manual screening. We are reporting our initial
experience with the TIS within one year of introduction
using a ''historical control". We intend to report the trends
in near future with more years of experience with TIS
which would show more clearly the advantage of TIS.
With the implementation of the new imager, one of the
changes included an adjustment by both the cytotechnol-
ogists and pathologists to the new stain. We have started
using the new stain six months prior to the introduction
of the TIS. Another important aspect of consideration was
the workforce issues and the various turnaround time
(TAT) parameters in the lab. One study has shown that the
TIS has made a significant positive impact on TAT and
workload [8]. In the near future we plan to look into the
effect of introduction of the TIS on various TAT parame-
ters.
The overall performance of the TIS in various clinical stud-
ies has demonstrated promising results. There appears to
be an increased detection of ASC-US (+) and HSIL (+). In
our laboratory the early evaluation of our experience with
the TIS has been highly satisfactory. The TIS appears to be
a promising tool in the cytology lab to improve the detec-
tion of cervical precursor lesions.
Abbreviations used
MS- Manual screening; TAT- turn around time; LBC- Liq-
uid-based cytology, CIN-Cervical intraepithelial neopla-
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